Skip to main navigation
Skip to search
Skip to main content
Utrecht University Home
Help & FAQ
Home
Research output
Search by expertise, name or affiliation
Contact Dermatitis in the Construction Industry
J.G. Timmerman
Research output
:
Thesis
›
Doctoral thesis 1 (Research UU / Graduation UU)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Contact Dermatitis in the Construction Industry'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Construction Industry
100%
Contact Dermatitis
100%
Construction Workers
28%
Confidence Interval
23%
Occupational Physician
19%
Expert Panel
14%
Gain-of-function mutation
14%
Dutch
9%
Odds Ratio
9%
Risk Factors
9%
Job-related
9%
Occupational Health Care
9%
Working Day
9%
Occupational Determinants
9%
Mutation in the Filaggrin Gene
9%
Filaggrin Gene
9%
Attributable Fraction
9%
Cumulative Exposure
4%
Employers
4%
Gene Loss
4%
Genetic Testing
4%
Work-related
4%
Prevalence Ratio
4%
Occupational Sector
4%
Vocational Training
4%
Irritant
4%
Gene Variants
4%
Occupational Diseases
4%
Prognostic Tool
4%
Strong Relation
4%
Preclinical Stage
4%
Self-reported Prevalence
4%
Current Prevalence
4%
Hazardous Substances
4%
Endogenous Risk
4%
Early Contact
4%
Skin Problems
4%
Biochemistry, Genetics and Molecular Biology
Prevalence
100%
Filaggrin
80%
Loss of Function Mutation
60%
Genetic Screening
20%
Awareness
20%
Gene Loss
20%
Nursing and Health Professions
Contact Dermatitis
100%
Confidence Interval
23%
Prevalence
23%
Occupational Physician
19%
Filaggrin
19%
Odds Ratio
9%
Health Care
9%
Physician
4%
Genetic Screening
4%
Occupational Disease
4%
Diseases
4%
Medicine and Dentistry
Contact Dermatitis
100%
Prevalence
23%
Filaggrin
19%
Loss of Function Mutation
14%
Health Care
9%
Occupational Health
9%
Odds Ratio
9%
Physician
4%
Occupational Disease
4%
Hazardous Material
4%
Gene Loss
4%
Genetic Screening
4%
Awareness
4%
Diseases
4%
Immunology and Microbiology
Contact Dermatitis
100%
Prevalence
23%
Loss of Function Mutation
14%
Awareness
4%
Gene Loss
4%
Genetic Screening
4%